戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 uate nucleus (ARC) to maintain low levels of serum prolactin.
2 nships between changes in CSF monoamines and serum prolactin and clinical outcome were examined, and
3                   Serial SPECT brain images, serum prolactin and extrapyramidal side effect ratings w
4 egnancy despite normal levels of circulating serum prolactin and pituitary prolactin production.
5  and spike duration of TIDA cells, increased serum prolactin can promote dopamine release to limit it
6 s were assessed by measuring the increase in serum prolactin concentration during 5 hours following s
7 osa, the fenfluramine-stimulated increase in serum prolactin concentration was significantly less tha
8 verse events, extrapyramidal symptom scores, serum prolactin concentration, body weight, and metaboli
9                                   Therefore, serum prolactin concentrations reflect endogenous seroto
10 SLE patients display hyperprolactinemia, and serum prolactin correlates with disease activity in some
11                                  Because the serum prolactin level is elevated at these times, we lat
12 nd cyclosporine are reported to increase the serum prolactin level, producing gynecomastia in men.
13 in, antiparkinson medication use, akathisia, serum prolactin level, QTc prolongation, and sedation.
14 of amenorrhea, galactorrhea, and an elevated serum prolactin level.
15        No significant change was observed in serum prolactin levels following Opra Kappa administrati
16                                              Serum prolactin levels increased during haloperidol trea
17                                          Her serum prolactin levels increased from 7 to 133 ng/mL (no
18                                              Serum prolactin levels increased significantly, and to a
19 at persistent mild-to-moderate elevations in serum prolactin levels induce a break in self tolerance
20                        Persistently elevated serum prolactin levels interfere with B cell tolerance i
21 ential effects of sustained "high" and "low" serum prolactin levels on bone mineral density and perip
22        These drugs are well known to elevate serum prolactin levels to varying degrees.
23                                              Serum prolactin levels were similar in both strains.
24 rolactin levels and a decrease in endogenous serum prolactin levels, indicating that ovine prolactin
25 e alpha-2 receptor subtype within the PVN on serum prolactin levels; however, the functional signific
26  significantly higher maximum mean levels of serum prolactin (men, 34.56 microg/L [95% CI, 29.75-39.3
27 ripiprazole was not associated with elevated serum prolactin or QTc prolongation.
28 pment was analyzed by selectively increasing serum prolactin (PRL) concentration in thymus-grafted co
29 udy was to evaluate the relationship between serum prolactin (PRL) concentrations and prolactinoma si
30  HF SCs during pregnancy and lactation, when serum prolactin (Prl) levels are highly elevated.
31                                  Circulating serum prolactin was elevated above temperate levels duri
32                    A concomitant increase in serum prolactin was observed in thymic-grafted nude mice
33 d 3-methoxy-4-hydroxyphenylglycol (MHPG) and serum prolactin were measured during drug-free and antip
34 th more weight gain and greater increases in serum prolactin, whereas haloperidol decanoate was assoc